Pharmabiz

Telangana DCA issues stop production orders to several cos over Revised Schedule M non-compliance

Telangana DCA issues stop production orders to several cos over Revised Schedule M non-compliance: Peethaambaran Kunnathoor, ...
Pharmabiz

Daiichi Sankyo submits Enhertu sNDA in Japan as adjuvant therapy for patients with HER2 positive early breast cancer

Daiichi Sankyo submits Enhertu sNDA in Japan as adjuvant therapy for patients with HER2 positive early breast cancer: Tokyo Monday, March 2, 2026, 12:00 Hrs [IST] Daiichi Sankyo h ...
Pharmabiz

WHO recommends influenza vaccine composition for the 2026-2027 northern hemisphere season

WHO recommends influenza vaccine composition for the 2026-2027 northern hemisphere season: Geneva Monday, March 2, 2026, 11:00 Hrs [IST] The World Health Organization (WHO) announ ...
Pharmabiz

ACC approves reappointment of Dr Raghuvanshi as DCGI for one more year

ACC approves reappointment of Dr Raghuvanshi as DCGI for one more year: Our Bureau, New Delhi Monday, March 2, 2026, 11:20 Hrs [IST] The Appointments Committee of the Cabinet (ACC ...
Pharmabiz

Industry confidence in connected packaging reaches new high

Our Bureau, Mumbai Monday, March 2, 2026, 10:00 Hrs [IST] Connected packaging will be increasingly important to the pa ...
Pharmabiz

University of Leeds equips students with skills to harness health data and informatics to drive evidence-based innovation

University of Leeds equips students with skills to harness health data and informatics to drive evidence-based innovation: Our Bureau, Bengaluru Monday, March 2, 2026, 09:00 Hrs [ ...
Pharmabiz

CDSCO soon to engage QCI certified notified bodies to augment drug regulatory audit capacity: DCGI

CDSCO soon to engage QCI certified notified bodies to augment drug regulatory audit capacity: DCGI: Shardul Nautiyal, Mumbai Monday, March 2, 2026, 08:00 Hrs [IST] India’s apex ...
Pharmabiz

KCDA asks Karnataka FDA to withdraw its recent circular on ‘Certificate of Analysis’

The Karnataka Chemists & Druggists Association (KCDA) has termed the recent circular issued by the Karnataka Food and Drugs Administration (FDA) on certificate of analysis as absurd. The FDA has ...
Pharmabiz

MDC recommends exemption to Intas Pharma's patented antipsychotic formulation from DPCO for five years

MDC recommends exemption to Intas Pharma's patented antipsychotic formulation from DPCO for five years: Gireesh Babu, New Delhi Monday, March 2, 2026, 08:00 Hrs [IST] The Multidis ...
Pharmabiz

DoP modifies incentive criteria for clinical investigations of medical devices under SDMI

DoP modifies incentive criteria for clinical investigations of medical devices under SDMI: Gireesh Babu, New Delhi Monday, March 2, 2026, 08:00 Hrs [IST] The Department of Pharmac ...
Pharmabiz

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Pharmabiz

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing: London Saturday, February 28, 2026, 13:00 Hrs [IST] ViiV Heal ...